The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Predictive score of early mortality in patients with solid tumors enrolled in phase I clinical trials.
 
Lisardo Ugidos
No Relationships to Disclose
 
Valentina Boni
No Relationships to Disclose
 
Elena Garralda
No Relationships to Disclose
 
Maria Jose de Miguel Luken
No Relationships to Disclose
 
Rafael Alvarez-Gallego
No Relationships to Disclose
 
Jesus Rodriguez-Pascual
No Relationships to Disclose
 
Estela Vega
No Relationships to Disclose
 
Cesar Munoz
No Relationships to Disclose
 
Cesar Garcia-Rey
No Relationships to Disclose
 
Antonio Cubillo
No Relationships to Disclose
 
Emiliano Calvo
Consulting or Advisory Role - Astellas Pharma; GlaxoSmithKline; Lilly/ImClone; Nanobiotix; Novartis; Pfizer; Roche/Genentech
Speakers' Bureau - Novartis
Research Funding - Abbvie; Boehringer Ingelheim; Bristol-Myers Squibb; Eisai; Janssen Oncology; Lilly; Merck; Millennium; Nektar; Novartis; OncoMed; Pfizer; PharmaMar; PsiOxus Therapeutics; Puma Biotechnology; Roche/Genentech; Sanofi; Spectrum Pharmaceuticals
Travel, Accommodations, Expenses - Lilly; Novartis; PsiOxus Therapeutics
Other Relationship - Pierre Fabre